We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPUS
8776
Hyperscale Data Inc
GPUS
$43.4M
0
BDR
8777
DELISTED
Blonder Tongue Laboratories Inc
BDR
$17K ﹤0.01%
17,394
-14,460
-45% -$14.2K
SKYS
8778
DELISTED
Sky Solar Holdings, Ltd.
SKYS
$17K ﹤0.01%
13,328
+4,026
+43% +$6.27K
MCF
8779
DELISTED
Contango Oil & Gas Co.
MCF
$17K ﹤0.01%
+10,025
New +$26.2K
CATX icon
8780
Perspective Therapeutics
CATX
$366M
$16K ﹤0.01%
3,901
-657
-14% -$2.75K
SHIP icon
8781
Seanergy Maritime Holdings
SHIP
$362M
$16K ﹤0.01%
+156
New +$58K
SSY
8782
DELISTED
SunLink Health Systems
SSY
$16K ﹤0.01%
+10,681
New +$16.4K
TAOP icon
8783
Taoping
TAOP
$8.39M
$16K ﹤0.01%
12
-54
-82% -$88.2K
WHLR
8784
Wheeler Real Estate Investment Trust
WHLR
$353K
0
VIVS
8785
CALL
VivoSim Labs
VIVS
$1.14M
$16K ﹤0.01%
128
-4
-3% -$756
VIRX
8786
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$16K ﹤0.01%
626
-251
-29% -$9.71K
EMAN
8787
DELISTED
eMagin Corporation
EMAN
$16K ﹤0.01%
+35,089
New +$19.5K
DTEA
8788
PUT
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$16K ﹤0.01%
+12,000
New +$15.7K
CLSD
8789
CALL
DELISTED
Clearside Biomedical
CLSD
$15K ﹤0.01%
+1,007
New +$18K
QNRX
8790
Quoin Pharmaceuticals
QNRX
$10.1M
0
TNK icon
8791
PUT
Teekay Tankers
TNK
$2.97B
$15K ﹤0.01%
1,450
-3,413
-70% -$31.1K
NYMX
8792
PUT
DELISTED
Nymox Pharmaceutical Corp
NYMX
$15K ﹤0.01%
10,200
-16,200
-61% -$28.3K
GEN
8793
DELISTED
Genesis Healthcare, Inc.
GEN
$15K ﹤0.01%
+12,408
New +$15.8K
ALO
8794
DELISTED
Alio Gold Inc
ALO
$15K ﹤0.01%
18,990
-13,107
-41% -$8.61K
QHC
8795
CALL
DELISTED
Quorum Health Corporation
QHC
$15K ﹤0.01%
10,900
+800
+8% +$1.31K
MTFB
8796
DELISTED
Motif Bio plc ADRs
MTFB
$15K ﹤0.01%
+23,606
New +$41K
BW icon
8797
Babcock & Wilcox
BW
$1.56B
$14K ﹤0.01%
+4,125
New +$15.9K
LGMK
8798
DELISTED
LogicMark
LGMK
$14K ﹤0.01%
+4
New +$16.2K
SYPR icon
8799
Sypris Solutions
SYPR
$49.2M
$14K ﹤0.01%
+18,333
New +$17.1K
TENX icon
8800
Tenax Therapeutics
TENX
$68.1M
$14K ﹤0.01%
+6
New +$14.5K

Similar funds

Ken Griffin's Q2 2019 Portfolio in Review

As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
  • Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.